LASANSELasa Supergenerics LimitedHighNeutral
Announced Wed, 13 Aug · 18:12 IST

Lasa Supergenerics Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.

Going ConcernQualified OpinionRevenue DeclinePat NegativeEbitda Margin CompressionExceptional ItemResults View source PDF

LASA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Lasa Supergenerics reported a sharp deterioration in Q1 FY26 results, with revenue from operations falling about 35% year-on-year to Rs 2,001.18 lakhs (vs Rs 3,083.55 lakhs in Q1 FY25). The company posted a net loss of Rs 2,111.92 lakhs, compared to a loss of Rs 273.16 lakhs in the same quarter last year, translating to a loss per share of Rs 4.22. The bulk of the loss comes from an exceptional item of Rs 2,057.47 lakhs tied to a major fire on May 18, 2025 at the company's main C-4 factory in Ratnagiri, which was uninsured and halted all production across the company's units. Management has flagged going concern uncertainty, noting it cannot restart manufacturing due to pending clearances and is exploring contract manufacturing or leasing options. The statutory auditor issued a modified review report citing the fire loss and going concern issues.

Likely market impact

This is a very negative filing for shareholders. Operations are fully halted, the company is loss-making with a qualified auditor's report and an explicit going concern warning, which raises real questions about the company's ability to continue as a going concern. Expect significant stock price pressure and heightened risk for investors.